These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2922356)

  • 1. Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patients.
    Zokufa HZ; Rodvold KA; Blum RA; Riff LJ; Fischer JH; Crossley KB; Rotschafer JC
    Pharmacotherapy; 1989; 9(1):10-6. PubMed ID: 2922356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of three methods for determining initial vancomycin doses.
    Ackerman BH
    DICP; 1989 Feb; 23(2):123-8. PubMed ID: 2728500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
    Garrelts JC; Godley PJ; Horton MW; Karboski JA
    Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized adjustment of vancomycin dosage: comparison with two dosage nomograms.
    Rybak MJ; Boike SC
    Drug Intell Clin Pharm; 1986 Jan; 20(1):64-8. PubMed ID: 3943460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
    Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
    J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new vancomycin dosing method.
    Musa DM; Pauly DJ
    Pharmacotherapy; 1987; 7(3):69-72. PubMed ID: 3628064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified vancomycin dosing protocol for treatment of diabetic foot infections.
    Niu SC; Deng ST; Lee MH; Ho C; Chang HY; Liu FH
    Am J Health Syst Pharm; 2008 Sep; 65(18):1740-3. PubMed ID: 18769001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
    Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
    Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A; Guglielmo BJ; Hersh AL
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine.
    Kildoo CW; Lin LM; Gabriel MH; Folli HL; Modanlou HD
    Dev Pharmacol Ther; 1989; 14(2):77-83. PubMed ID: 2630235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Strategy for Dosing Vancomycin to Therapeutic Targets Using Only Trough Concentrations.
    Prybylski JP
    Clin Pharmacokinet; 2017 Mar; 56(3):263-272. PubMed ID: 27389404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a Bayesian method to monitor and adjust vancomycin dosage regimens.
    Hurst AK; Yoshinaga MA; Mitani GH; Foo KA; Jelliffe RW; Harrison EC
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1165-71. PubMed ID: 2393277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment.
    Hong J; Krop LC; Johns T; Pai MP
    Pharmacotherapy; 2015 May; 35(5):455-63. PubMed ID: 26011138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
    Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin pharmacokinetics and dosing in premature neonates.
    McDougal A; Ling EW; Levine M
    Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.